Categories: Health

Explainer : What you need to know about DRDO’s anti-Covid medicine 2-DG

<p>
A medicine to treat Covid-19 patients , developed by the Defence Research and Development Organisation, has been approved for emergency use after year-long trials and represents a major advance in the country’s fight against the deadly Covid-19 disease.</p>
<p>
<strong>How does it work?</strong></p>
<p>
The drug, 2-deoxy-D-glucose (2-DG) enters the body and  accumulates in the cells infected by the virus. It then stalls the energy production and metabolic reaction of the virus and stops it from multiplying. DRDO says its "selective accumulation in only virally infected cells" makes it unique.</p>
<p>
<iframe allow="accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture" allowfullscreen="" frameborder="0" height="315" src="https://www.youtube.com/embed/Xyl66QmxNZ0" title="YouTube video player" width="560"></iframe></p>
<p>
<strong>How is it consumed?</strong></p>
<p>
The medicine comes in powdered form and has to be taken orally by dissolving it in water.</p>
<p>
<strong>Is it a game changer ?</strong></p>
<p>
The drug could speed up recovery of hospitalised patients and reduce their dependence on medical oxygen. In hospital trials, it was found that 42% of the patients, who were administered two sachets of the drug daily, came off oxygen support by the third day. Under standard treatment, just 30% of the patients come off oxygen support by day 3.</p>
<p>
While the medicine has been found effective in moderate and severe Covid cases and works well even in people above 65 years, it has been granted the emergency use authorisation as an adjunct therapy. In other words, it is no miracle cure and will be part of the treatment protocol involving other elements.</p>
<p>
<strong>How much will it cost?</strong></p>
<p>
The price has not been announced yet but sources say each sachet is expected to cost Rs 500-600. DRDO says 2-DG can be easily mass-produced.</p>
<p>
Dr Reddy's Lab, DRDO's industry partner on this project, has already started producing a limited quantity of the drugs for hospitals. It will not be available over the counter at present.</p>
<p>
<strong> <a href="https://www.pib.gov.in/PressReleasePage.aspx?PRID=1717007">DCGI approves anti-COVID drug developed by DRDO for emergency use</a></strong></p>
<p>
<a href="https://www.pib.gov.in/PressReleasePage.aspx?PRID=1717007"><br />
</a></p>

IN Bureau

Recent Posts

Hezbollah media chief killed in Israeli strike on Beirut

An Israeli strike in the Lebanese capital Beirut killed Hezbollah's media relations chief Mohammed Afif…

19 minutes ago

“Trade between India-Brazil is USD 15 bn, huge potential to explore”: Executive Director, India-Brazil Chamber of Commerce

Executive Director of India-Brazil Chamber of Commerce Leonardo Ananda Gomes highlighted the successful bilateral trade…

24 minutes ago

PM Modi meets Nigerian President Bola Ahmed Tinubu

Prime Minister Narendra Modi met with Nigerian President Bola Ahmed Tinubu at the Presidential Villa…

16 hours ago

COP29: India expresses dissatisfaction with developed countries over climate finance

At the ongoing COP29 climate conference in Azerbaijan, India expressed dissatisfaction on the insistence of…

18 hours ago

China’s youth unemployment crisis sparks ‘pretend work’ trend, grows desperation

Rampant youth unemployment in China has left millions of young people struggling, staying at home,…

18 hours ago

Nepal and India discuss movement of third-country nationals at annual border security coordination meeting

The eighth annual Nepal-India border security coordination meeting commenced in Kathmandu on Saturday, with security…

18 hours ago